IIPLA News
Thursday, May 14, 2026

Ward and Smith Launches Free IP Summer School Webinar Series for Business Professionals

The four-part series offers practical insights on trade secrets, AI patents, trademarks, and IP litigation from leading IP attorneys

IIPLA News Deskanonymous access0 articles left this week
Ward and Smith Launches Free IP Summer School Webinar Series for Business Professionals
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Ward and Smith, P.A. has announced the launch of IP Summer School, a complimentary four-part webinar series running from May through August 2026. Designed for clients and business professionals involved in intellectual property creation and protection, the sessions cover trade secrets, AI and patents, trademark fundam…
Share This Article
Ready-to-post copy includes the article link.

Ward and Smith Launches Free IP Summer School Webinar Series for Business Professionals Ward and Smith, P.A. has announced the launch of IP Summer School, a complimentary four-part webinar series running from May through August 2026. Designed for clients and business professionals involved in intellectual... Read the full IIPLA article: https://iipla.org/news/ward-and-smith-launches-free-ip-summer-school-webinar-series-for-business-professionals

Related Coverage

Continue in the newsroom

Back to newsroom
LitigationGlobal

Denny Hamlin Publicly Supports Joe Gibbs Racing Amid Ongoing IP Litigation

Denny Hamlin, prominent NASCAR driver, has voiced his support for Joe Gibbs Racing (JGR) amid an ongoing intellectual property lawsuit involving the racing team. Hamlin’s defense highlights his commitment to JGR and underscores the team’s stance during the legal dispute. This development adds a personal dimension to t…

Thursday, May 14, 2026
PatentsUSA

Zydus Life Settles Patent Dispute with Astellas for $120 Million Over Bladder Medication

Zydus Life Sciences, an Indian pharmaceutical company, has reached a $120 million settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation related to the bladder drug mirabegron. The settlement ends the dispute over patent rights in the United States, allowing both parties to avoid protracte…

Thursday, May 14, 2026